FDA Approved: PAZOPANIB — Supplemental Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)

View source ↗

Summary

FDA approved a supplemental application for pazopanib from Sun Pharmaceutical Industries, Inc. (ANDA 215837).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma
• Soft Tissue Sarcoma

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

SUPPL AP for PAZOPANIB (PAZOPANIB)